Programme Members

Programme Contacts

University of Cambridge
Not applicable/other
Programme Lead and Training Representative
Cambridge University Hospitals NHS Foundation Trust
Not applicable/other
Programme Lead
University of Cambridge
Cancer Research UK Cambridge Institute, Department of Oncology
Programme Manager

Selected publications

  • All members
  • Group leaders
  • Clinical consultants
University of Cambridge
Department of Oncology
PI:
N
CC:
N
University of Cambridge
Department of Chemistry
My group's research interests lies under the broader field of Chemical Biology. In particular, we are developing novel site-specific and...
PI:
Y
CC:
N
University of Cambridge
Department of Pathology
PI:
Y
CC:
N
AstraZeneca
Not applicable/other
Oncology
Oncology Biologics drug discovery
PI:
Y
CC:
N
University of Cambridge
Department of Pathology
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Medicine
PI:
N
CC:
N
University of Cambridge
Not applicable/other
MRC Toxicology Unit, National Blood Service
Our long-term aim is to understand the interplay between the myriad pathways involved in the pathogenesis of multiple myeloma so that these...
PI:
Y
CC:
Y
Cambridge University Hospitals NHS Foundation Trust
Not applicable/other
PI:
N
CC:
N
University of Cambridge
Not applicable/other
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust, ImBio
Not applicable/other
PI:
N
CC:
N
ImBio
Not applicable/other
ImBio
Developing cancer therapy as opposed to research. Autologous tumour-dendritic cell fusion hybrids for cancer therapy
PI:
Y
CC:
N
University of Cambridge
Department of Oncology
PI:
N
CC:
N
University of Cambridge
Department of Biochemistry
Current research aims to generate and functionally validate recombinant antibodies to cell surface receptors, growth factors or signalling...
PI:
N
CC:
University of Cambridge
Department of Pathology
Cancer genetics: application in prognosis and treatment stratification
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
MedImmune
Not applicable/other
Oncology
Cancer Immunotherapy- In vitro profiling of immunostimulatory antibodies as well as elucidation of antibody efficacy and target rationale
PI:
N
CC:
Other
Not applicable/other
PI:
N
CC:
N
University of Cambridge
Department of Pharmacology
PI:
Y
CC:
N
University of Cambridge
Not applicable/other
PI:
N
CC:
N
University of Cambridge
Department of Pathology
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Cancer Research UK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Department of Medicine
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute, Department of Oncology
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Department of Pathology
PI:
Y
CC:
N
University of Cambridge
Department of Medicine
Cambridge Institute for Medical Research
My long standing research interest has involved understanding the genetic basis of susceptibility to autoimmune disease. More recently I...
PI:
N
CC:
University of Cambridge
Department of Pharmacology
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Department of Pathology
PI:
Y
CC:
N
University of Cambridge, Cambridge University Hospitals NHS Foundation Trust
Department of Medicine
PI:
Y
CC:
Y
University of Cambridge
Department of Clinical Neuroscience
1: Application of nanotherapy to target endogenous neural stem cells in vivo for treatment of neurodegenerative diseases. 2: Application of...
PI:
Y
CC:
University of Cambridge
Department of Clinical Neuroscience
PI:
N
CC:
N
University of Cambridge
Department of Oncology
CRUK Cambridge Institute
The Murphy Group studied cell surface proteinases that modulate both the extracellular matrix and the activities of key cytokines and...
PI:
Y
CC:
N
University of Cambridge
Department of Medicine
PI:
Y
CC:
N
Babraham Institute
Not applicable/other
PI:
Y
CC:
N
MISSION Therapeutics Ltd
Not applicable/other
Biology
Discovery and development of novel oncology drugs by inhibiting deubiquitylating enzymes within the DNA damage response, expoliting the...
PI:
N
CC:
University of Cambridge
Not applicable/other
PI:
N
CC:
N
Other
Not applicable/other
Kymab Ltd
I have 20 years of oncology research experience acquired both in academia (UC Irvine, USA and University of Oxford, UK) and industry (Kymab...
PI:
N
CC:
N
University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, MRC Laboratory of Molecular Biology
Department of Medicine
Honorary Specialty Registrar at Addenbrooke's Hospital
PI:
N
CC:
N
Babraham Institute
Department of Haematology, Department of Computer Laboratory
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Not applicable/other
(tbc)
PI:
N
CC:
Y
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge
Department of Haematology
PI:
Y
CC:
N
University of Cambridge
Department of Pathology
PI:
Y
CC:
N
University of Cambridge
Department of Medicine
Cambridge Institute for Medical Research
I am interested in determining how human cytomegalovirus and other intracellular pathogens evade innate immunity. We recently developed ?...
PI:
Y
CC:
Y
University of Cambridge
Department of Oncology
PI:
N
CC:
N